Base period (year 1) management and research support for the genetic and rare diseases (gard) information center and related programs. POP: 07/29/2021 to 07/28/2022.
Ended Awarded Last action
- Contract number
- 75N95021F00084
- Awardee
-
ICF Incorporated, L.L.C. UEI QHBLBNKKV4U3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $9,593,687
Award facts
- Opportunity
-
- 75N95021Q00239 Solicitation number
- Contract value 100% obligated
- $9,593,686.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Time and Materials
- Place of performance
- Fairfax, VA 22031, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$485,716 | |
| Exercise an Option | $49,237 | |
| Exercise an Option | $3,455,709 | |
| Exercise an Option | $1,000,000 | |
| Exercise an Option | $2,755,284 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,819,173 |
About this award
The National Institute on Drug Abuse issued a delivery order to ICF Incorporated, L.L.C. on July 29, 2021, under the Multiple Award Schedule (MAS) for management and research support of the Genetic and Rare Diseases (GARD) Information Center, with a ceiling value of $9.593 million and ultimate completion date of July 28, 2024.
Place of performance is Fairfax, VA. The order is priced on a time-and-materials basis. The base period (Year 1) ran from July 29, 2021 to July 28, 2022; FY26 UDO Initiative work followed.
Service Contract Inventory data reflects government-invoiced labor from FY2021 through FY2024. The order ramped from 1.8 FTEs and 3,728 contractor hours in FY2021 ($411 thousand invoiced) to a peak of 15.5 FTEs and 32,272 contractor hours in FY2023 ($3.7 million invoiced), then contracted to 11.9 FTEs and 24,690 contractor hours in FY2024 ($3.3 million invoiced). Derived government-paid hourly rates rose from $110.35 in FY2021 to $132.77 in FY2024. ICF self-performed all reported hours; no subcontractors were reported under this order.
Quick answers
Who was awarded contract 75N95021F00084?
75N95021F00084 was awarded to ICF Incorporated, L.L.C. by National Institute on Drug Abuse (National Institutes of Health) on July 29, 2021.
How much is contract 75N95021F00084 worth?
The government has obligated $9,593,687 on 75N95021F00084.
Is contract 75N95021F00084 an order under another contract?
Yes. 75N95021F00084 is a delivery order under GS00F010CA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75N95021F00084 competed?
The extent of competition for 75N95021F00084 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award